Study ID: ALS-GA-201
Study Title
- Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
Teva Identifier
- ALS-GA-201
ClinicalTrials.gov Identifier
- NCT00326625
Study Status
- Completed
Trial Condition(s)
- Amyotrophic Lateral Sclerosis
Interventions
- Drug: 40 mg glatiramer acetate | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- July 31, 2006 - July 31, 2008
Phase
- Phase 2
Study Type
Interventional
